In the News
Latest News:
Trial to Test Donanemab in People With Alzheimer’s Signs, Not Symptoms
July 20, 2021
Alzheimer's News Today
Lilly and Banner Alzheimer's Institute collaborate on planned Phase 3 prevention trial of donanemab
July 15, 2021
PR Newswire
Many Alzheimer’s Experts Say Use of Aduhelm Should Be Sharply Limited
June 22, 2021
The New York Times
Alzheimer’s Disease: FDA Rolls Out Prescribing Information for Aducanumab
June 14, 2021
BreakingMED.org
Dementia Experts on Why the FDA Approval of Aducanumab for Alzheimer’s Gets Mixed Grades.
June 09, 2021
Neurology Today
A Drug to Treat Alzheimer's Was Approved. Now What?
June 08, 2021